OTC Healthcare in Switzerland
Euromonitor International's OTC Healthcare in Switzerland market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 90 | Publication date: Jun 2006
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Executive summary
Sales revive slightly in 2005
Compared to 2004, sales of OTC products saw a revival, due to the solid growth of smaller sectors and the positive performance of cold and cough remedies as a result of a long and hard winter season in 2005.
Apart from that, key players reacted to last year’s stagnating sales by intensifying marketing activities and efforts to strengthen consumer awareness.
Dynamic growth of small sectors
While not overwhelming, the development of small sectors such as smoking cessation aids and sleeping and calming products was steady and reliable. These are either driven by public health policies (such as smoking cessation aids) or benefit from specific external conditions: calming and sleeping products are in demand in an increasingly noisy and stressful society, eye care sales performed well mostly due to the increased incidence of allergies.
For large manufacturers these sectors represent opportunities to round off their portfolio with promising niche products, for small players they can become drivers of growth and fields of valuable special expertise.
Drugstores face strong competition from mass retailers
Over the review period, distribution shares of drugstores/parapharmacies fell by around two percentage points to reach almost 19% in 2005. Mass retailers on the other hand, saw a strong increase of over one percentage point, on 2000 to account for over 1% in 2005.
Consumer studies also indicated that the quality of cheaper discount products is not that far behind that of premium ones, therefore, the purchase of cheaper and more convenient discount products presents an increasingly appealing option.
Distribution: independent outlets face difficult times
OTC distribution is increasingly driven by price competition and product promotion. This has put independent outlets – still the typical form of pharmacies and drugstores – into a difficult strategic position. On the one hand, domestic company Galenica has built a formidable chain of pharmacies over the past seven years, enabling economies of scale and scope and thus lower prices.
On the other hand, drugstores face stiff competition from mass retailers, most notably the large supermarket chains of Migros and Coop, which have made inroads into the sale of certain OTC product categories.
Swiss can and are willing to afford a good healthcare system
Swiss are willing to spend a lot of money on their health, as can be seen in the healthcare expenditure of the country, which accounted for over 11% of GDP in 2005. This is comparable with healthcare expenditure in Germany and puts these countries in the top positions in Europe when it comes to healthcare expenditure.
Table of contents
OTC HEALTHCARE IN SWITZERLAND : MARKET INSIGHT
EXECUTIVE SUMMARY
OPERATING ENVIRONMENT
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Traditional Remedies
Homeopathy
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
Life Expectancy
Table 2 Life Expectancy at Birth 2000-2005
OTC HEALTHCARE SALES
Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
Switches
Table 5 OTC Healthcare Switches 2004-2005
Competitive Environment
Table 6 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 7 OTC Healthcare Brand Shares by Retail Value 2002-2005
Retail Distribution
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
Retailer Activity and Private Label Trends
Table 10 Penetration of Private Label by Sector 2001-2005
Forecast Market Performance
Table 11 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 12 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
DEFINITIONS
LOCAL COMPANY PROFILES - SWITZERLAND
BIOFORCE AG - OTC HEALTHCARE - SWITZERLAND
COMPANY BACKGROUND
RECENT NEWS
Summary 1 Summary - Bioforce AG: Operational Indicators 2004
PRODUCTION CAPACITY
GALENICA HOLDING AG - OTC HEALTHCARE - SWITZERLAND
COMPANY BACKGROUND
RECENT NEWS
Summary 2 Summary - Galenica Holding AG: Operational Indicators 2004
PRODUCTION CAPACITY
NOVARTIS CONSUMER HEALTH AG - OTC HEALTHCARE - SWITZERLAND
COMPANY BACKGROUND
RECENT NEWS
Summary 3 Summary - Novartis Consumer Health Schweiz AG: Operational Indicators 2004
PRODUCTION CAPACITY
SPIRIG PHARMA AG - OTC HEALTHCARE - SWITZERLAND
COMPANY BACKGROUND
RECENT NEWS
PRODUCTION CAPACITY
ANALGESICS IN SWITZERLAND
SECTOR PERFORMANCE
2005 headlines
Sales of analgesics recover after a slump in 2004
Adult analgesics
Child-specific analgesics
Topical analgesics
Forecast performance
Table 13 Sales of Analgesics by Subsector: Value 2000-2005
Table 14 Sales of Analgesics by Subsector: % Value Growth 2000-2005
Table 15 Analgesics Company Shares by Retail Value 2001-2005
Table 16 Analgesics Brand Shares by Retail Value 2002-2005
Summary 4 Summary - Analgesics: New Product Launches 2004-2005
Table 17 Forecast Sales of Analgesics by Subsector: Value 2005-2010
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2005-2010
TOPICAL ANALGESICS BY HERBAL/STANDARD SPLIT
Only one fifth of topical analgesics is made up by herbal preparations
Herbal preparations are rather inconvenient
Table 19 Herbal vs Standard Topical Analgesics 2000/2005
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN SWITZERLAND
SECTOR PERFORMANCE
2005 headlines
A cold, long winter boosts sales of cough and cold remedies
Growing number of allergies brings healthy growth to allergy remedies
Retail prices remain stable
New product launches not really innovative
Medicated confectionery makes up the lion’s share in this sector
Forecast performance
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2000-2005
Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2000-2005
Table 22 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2001-2005
Table 23 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2002-2005
Summary 5 Summary - Cough, Cold and Allergy (Hay Fever) Remedies: New Product Launches 2004-2005
Table 24 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2005-2010
Table 25 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2005-2010
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES BY HERBAL/STANDARD SPLIT
Herbal alternatives play an important role in this sector
Medicated confectionery is largely dominated by the use of herbal ingredients
Table 26 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2000/2005
DECONGESTANTS PERFORMANCE
Decongestant sales benefit from a long and cold winter
Inhalant decongestants copes with rather low sales figures
Table 27 Sales of Decongestants by Type: Value 2000-2005
Table 28 Sales of Decongestants by Type: % Value Growth 2000-2005
CHILD-SPECIFIC COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES PERFORMANCE
Parents still sceptical about OTC child-specific products
Child-specific allergy remedies show stable growth, while cough and cold products lag behind
Table 29 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2000-2005
Table 30 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2000-2005
DIGESTIVE REMEDIES IN SWITZERLAND
SECTOR PERFORMANCE
2005 headlines
Marginal growth of digestive remedies in 2005
Child-specific digestive remedies see healthy growth
Niche H2 blockers shows the fastest growth of digestive remedies
Marginal price increases due to a weak demand
Laxatives are going down
Diarrhoeal and motion sickness remedies benefit from revived travel
Forecast performance
High fragmentation of digestive remedies makes effective marketing rather difficult
Table 31 Sales of Digestive Remedies by Subsector: Value 2000-2005
Table 32 Sales of Digestive Remedies by Subsector: % Value Growth 2000-2005
Table 33 Digestive Remedies Company Shares by Retail Value 2001-2005
Table 34 Digestive Remedies Brand Shares by Retail Value 2002-2005
Summary 6 Summary - Digestive Remedies: New Product Launches 2004-2005
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2005-2010
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2005-2010
DIGESTIVE REMEDIES BY HERBAL/STANDARD SPLIT
Herbal products gain popularity among Swiss consumers
Table 37 Herbal vs Standard Digestive Remedies 2000/2005
OTHER INDIGESTION AND HEARTBURN REMEDIES PERFORMANCE
Other indigestion and heartburn remedies see a stable growth
Top brand Rennie boosts sales of antacids and revives the whole subsector
Table 38 Sales of Other Indigestion and Heartburn Remedies by Type: Value 2000-2005
Table 39 Sales of Other Indigestion and Heartburn Remedies by Type: % Value Growth 2000-2005
MEDICATED SKIN CARE IN SWITZERLAND
SECTOR PERFORMANCE
2005 headlines
Low overall growth of medicated skin care in 2005
Child-specific medicated skin care fastest growing subsector in 2005
Rising incidence of allergies boosts topical allergy remedies
Prices static in weak environment
Skin care sector lacks new impulses
Hair loss treatments benefit from its cosmetic value
Slow growth of antiseptics and antipuritics
Forecast performance
Table 40 Sales of Medicated Skin Care by Subsector: Value 2000-2005
Table 41 Sales of Medicated Skin Care by Subsector: % Value Growth 2000-2005
Table 42 Medicated Skin Care Company Shares by Retail Value 2001-2005
Table 43 Medicated Skin Care Brand Shares by Retail Value 2002-2005
Summary 7 Summary - Medicated Skin Care: New Product Launches 2004-2005
Table 44 Forecast Sales of Medicated Skin Care by Subsector: Value 2005-2010
Table 45 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2005-2010
MEDICATED SKIN CARE BY HERBAL/STANDARD SPLIT
Herbal products gain further importance
Table 46 Herbal vs Standard Medicated Skin Care 2000/2005
ACNE TREATMENTS BRAND SHARES
Two strong players in a rather fragmented market
Table 47 Acne Treatments Brand Shares by Retail Value 2002-2005
HAIR LOSS TREATMENTS BRAND SHARES
Regaine remains the top hair loss treatment brand
Table 48 Hair Loss Treatments Brand Shares by Retail Value 2002-2005
VITAMINS AND DIETARY SUPPLEMENTS IN SWITZERLAND
SECTOR PERFORMANCE
2005 headlines
Weak performance due to the strong competition from private label products
Price increases have little to no impact on the market
Fish oils grow fastest
while tonics continuously lose out
Mineral combination products lose out to the benefit of specific ones
Forecast performance
Oversaturation and cheap private label products will keep value growth low
Fish oils will remain the fastest growing subsector
Herbal dietary supplements will benefit from stable growth rates
Table 49 Sales of Vitamins and Dietary Supplements by Subsector: Value 2000-2005
Table 50 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2000-2005
Table 51 Vitamins and Dietary Supplements Company Shares by Retail Value 2001-2005
Table 52 Vitamins and Dietary Supplements Brand Shares by Retail Value 2002-2005
Summary 8 Summary - Vitamins and Dietary Supplements: New Product Launches 2004-2005
Table 53 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2005-2010
Table 54 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2005-2010
VITAMINS PERFORMANCE
Rather weak performance of vitamins in 2005
Low consumer confidence in multivitamins
Vitamin D grew fastest in 2005
Fierce competition within vitamins
Table 55 Sales of Vitamins by Type: Value 2000-2005
Table 56 Sales of Vitamins by Type: % Value Growth 2000-2005
Table 57 Vitamins Brand Shares by Retail Value 2002-2005
DIETARY SUPPLEMENTS PERFORMANCE
Dietary supplements recover from rather slow growth during the last few years
The small niches of eye health, Q10 and fish oil lack strong players
Minerals dominate value
Table 58 Sales of Dietary Supplements by Type: Value 2000-2005
Table 59 Sales of Dietary Supplements by Type: % Value Growth 2000-2005
Table 60 Dietary Supplements Brand Shares by Retail Value 2002-2005
Table 61 Dietary Supplements by Positioning: % Retail Value Analysis 2005
NRT SMOKING CESSATION AIDS IN SWITZERLAND
NUMBER OF SMOKERS
Numbers of male smokers decreasing while more and more women start to smoke
Public politics against tobacco
Table 62
SECTOR PERFORMANCE
2005 headlines
Market grows by almost 4% and outperforms last year’s growth rates
NRT gums are the most popular format
NRT patches a dynamic subsector
Small price increases across all subsectors
Key player Pfizer dominates sector shares with its highly successful Nicorette brand
Forecast performance
Table 63 Sales of NRT Smoking Cessation Aids by Subsector: Value 2000-2005
Table 64 Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2000-2005
Table 65 NRT Smoking Cessation Aids Company Shares by Retail Value 2001-2005
Table 66 NRT Smoking Cessation Aids Brand Shares by Retail Value 2002-2005
Table 67 Forecast Sales of NRT Smoking Cessation Aids by Subsector: Value 2005-2010
Table 68 Forecast Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2005-2010
EYE CARE IN SWITZERLAND
SECTOR PERFORMANCE
2005 headlines
Growth rate down compared to 2004
Price increases small in competitive sector
Strong potential of allergy eye care, while sales of standard eye care are moderate
Only a handful of manufacturers dominate sales of eye care products
Forecast performance
Table 69 Sales of Eye Care by Subsector: Value 2000-2005
Table 70 Sales of Eye Care by Subsector: % Value Growth 2000-2005
Table 71 Eye Care Company Shares by Retail Value 2001-2005
Table 72 Eye Care Brand Shares by Retail Value 2002-2005
Summary 9 Summary - Eye Care: New Product Launches 2004-2005
Table 73 Forecast Sales of Eye Care by Subsector: Value 2005-2010
Table 74 Forecast Sales of Eye Care by Subsector: % Value Growth 2005-2010
EAR CARE IN SWITZERLAND
SECTOR PERFORMANCE
Ear care falls on deaf ears among consumers
ADULT MOUTHCARE IN SWITZERLAND
SECTOR PERFORMANCE
Growth is assumed to remain stable
CALMING AND SLEEPING PRODUCTS IN SWITZERLAND
SECTOR PERFORMANCE
Stressful lifestyles keep Swiss awake, assuring stable growth of calming and sleeping products
WOUND TREATMENTS IN SWITZERLAND
SECTOR PERFORMANCE
2005 headlines
Slower growth than in 2004
Sticking plasters show further dynamic growth
Other wound treatments grow stronger compared to 2004
Little room for price increases in weak environment
Forecast performance
Table 75 Sales of Wound Treatments by Subsector: Value 2000-2005
Table 76 Sales of Wound Treatments by Subsector: % Value Growth 2000-2005
Table 77 Wound Treatments Company Shares by Retail Value 2001-2005
Table 78 Wound Treatments Brand Shares by Retail Value 2002-2005
Summary 10 Summary - Wound Treatments: New Product Launches 2004-2005
Table 79 Forecast Sales of Wound Treatments by Subsector: Value 2005-2010
Table 80 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2005-2010
EMERGENCY CONTRACEPTION IN SWITZERLAND
SECTOR PERFORMANCE
Medical consultation required for the sale of emergency contraception